Bavarian Nordic Reports Further Data On PROSTVAC(TM)

Bavarian Nordic announced that the first detailed data on PROSTVAC(TM) since the vaccine was licensed from the National Institutes of Health (NIH) is now available. The data, that once again confirms the excellent safety and efficacy results previously reported, will be presented at the 2009 Genitourinary Cancers Symposium (GU) on February 26-28, 2009 in Orlando, Florida.

More: continued here

Filed under: Prostate on March 11th, 2009